The Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium has launched a project designed to seek regulatory qualification of new biomarkers that predict the change in joint damage over time from osteoarthritis (OA) in the knee. [Source: American Academy of Orthopaedic Surgeons]

Consortium Seeks Regulatory Qualification of Biomarkers for Knee OA

New research plans to validate the highest performing radiographic measures, MRI measures, and biochemical markers from 2015 project
A study by researchers at Yale School of Medicine has concluded that progesterone receptor (PR) levels are an important predictor of whether women with endometriosis will respond to first-line

Biomarkers Predict Responsiveness to First-Line Treatment for Endometriosis

Progesterone receptor status in endometriotic lesions may offer a targeted approach to treating endometriosis, Yale researchers conclude
A team of researchers has concluded that the MAP2K3 gene could prove to be a promising target for new drugs that reduce age-related memory decline—and possibly

Gene Offers Insights into the Sharp Memory of Adult ‘SuperAgers’

Researchers say MAP2K3 inhibitors may represent a novel therapeutic strategy for enhanced cognition and resistance to Alzheimer's disease

NAS Urges “Rapid Learning System” to Accelerate Personalized Medicine

Biomarker tests for molecularly targeted therapies need better evidence and oversight, insists National Academy of Sciences.
NuMedii will partner with Yale School of Medicine and Brigham and Women’s Hospital on research designed to apply single-cell sequencing toward identifying novel precision therapies and biomarkers in idiopathic pulmonary fibrosis (pictured). [Pathology Education Informational Resource (PEIR) Digital Library]

Yale School of Medicine, BWH Tapped by NuMedii for IPF Biomarker Collaboration

Collaboration combines single-cell RNA sequencing data repository, NuMedii’s Artificial Intelligence for Drug Discovery (AIDD) technology.
Bacteriophage life cycle [Anne Chevallereau and colleagues]

Using OMIC Techniques to Understand Phage Therapy Virus

Next-generation approaches detail bacteriophage life cycle as it replicates inside P. aeruginosa.
10x Genomics said today it has acquired Spatial Transcriptomics for an undisclosed price. Based in Stockholm

10x Genomics Maintains Expansion with Spatial Transcriptomics Acquisition

Based in Stockholm, Spatial Transcriptomics offers technology designed to allow RNA sequencing to perform in 2D
Source: © agsandrew / Fotolia

OHSU Gains Exclusive Rights to Biocept’s Liquid Biopsy Testing in Oregon

Biocept’s Target Selector liquid biopsy platform is designed to capture and analyze tumor-associated molecular markers in CTCs and ctDNA
Provista Diagnostics researchers say the company's Videssa® Breast test can help inform better decision-making after abnormal mammogram or other breast imaging results and potentially reduce the use of traditional biopsy by up to 67%. (Source: [iStock/David Marchal)

Omics and Tumor Morphology Point to Possible Breast Cancer Outcome Biomarker

Integrating multiple types of biological data for cancer samples is key to identifying potential biomarkers that can predict patient outcome. That’s the conclusion of a...
MDxHealth and QUT bluebox say their planned liquid biopsy epigenetic assay will evaluate abnormal DNA methylation changes

MDxHealth, QUT Partner to Develop Oral Cancer Liquid Biopsy Assay

The saliva test will evaluate abnormal DNA methylation changes to indicate whether a patient may be at higher risk of developing cancer
Scroll Up